Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: jack w garnes jr. who wrote (3779)	12/16/1997 8:32:00 PM
From: Leo Francis	Respond to of 23519

DB, you all right? LF

To: jack w garnes jr. who wrote (3779)	12/16/1997 8:40:00 PM
From: Zebra 365	Read Replies (3) \| Respond to of 23519

Jack, There may be a few greedy shorts left, but I have to believe that short interest is down dramatically at this point. Unfortunately, many longs forget that it is often the shorts who support the price of a stock when no one else will step in to buy, lose the shorts and the price drops even faster. Your point and pain are well taken. I happend to get a consult back today on a patient from one of the busiest impotence urologists in North Dallas. He started my patient on MUSE and Actis just last week. I called him up (the urologist) to get his take on MUSE. He said he's seeing about a 40% refill / continuation rate. (This is consistent with the research showing 65% intercourse in the 60% of unscreened patients that react at all.) 0.65 x 0.60 = 0.39 He said if I were interested in starting patients on it myself, I could do home titration with the 500mg dose. Just Rx the 500mg six pack have them try one, and if no effect in 20 minutes use a second. He doesn't bother with the 125mg and 250mg strengths. Tells them to be careful of orthostasis (BP drop). He said it works best when used with Actis (the Vivus "cockring") and said he has seen no cases of priapism (erection over six hours) in several thousand patients. He is also skeptical of Viagra for the same reasons as many physicians are (tough to get effective levels where you want them and not where you don't) Second bright point, the ad for MUSE is in the new JAMA December 17,1997 opposite page 2044 in my issue, (probably focused to internists). Full page, yellow and black background (trafic sign colors) 2/3 of page in 30 point type: YOUR PATIENTS ARE ABOUT TO START ASKING SOME VERY PERSONAL QUESTIONS. WILL YOU FEEL COMFORTABLE ENOUGH TO ANSWER THEM? On February 1st, VIVUS will launch the largest direct-to-consumer advertising campaign for the treatment of erectile dysfunction. That means millions of impotent men will know there is an effective treatment currently available called MUSE. To make sure you're prepared to answer your patients' questions about MUSE, call 1-888-345-MUSE or visit our website at www.vivus.com. Then get ready for some very candid conversations. Local Problem. Local Solution. The answer is......MUSE Just got it in the mail today, added another 1,000 shares to the stable to celebrate. Like the dig at Viagra "Local Problem. Local Solution." Sorry, BigKNY3. Cheers, Zebra